Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
Firms are offering extra incentives to advisor compensation plans like paid time off for volunteer work, and even free financial planning.
Wells Fargo Advisors is hoping it can cross-sell products to customers in other business lines, specifically banking customers.
The noted economist Nouriel Roubini cited five major issues that our species will have to confront over the next two decades.